Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / COSMEDICIAN AP SDN BHD

Clinicaltrial registered3 Nov 2026

COSMEDICIAN AP SDN BHD

3 Nov 2026: Trial registered · Pilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne Scars. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
3 Nov 2026
Title
Pilot Study of Combination Treatment With Subcision, Human Adipose Tissue-Derived Exosomes and Powdered Polydioxanone for Atrophic Acne Scars
Conditions
Atrophic Acne Scars
Phase
Not applicable
Study Type
Interventional
Status
Completed
Countries
Malaysia
Country
Malaysia
Reference
NCT07914322
Location
Malaysia
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at COSMEDICIAN AP SDN BHD

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Malaysia

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.